Report - La terapia del NSCLC in fase precoce, mesotelioma e ...media.aiom.it/userfiles/files/doc/AIOM-Servizi/slide/20170929PI_21_Grossi.pdfdurvalumab 10 mg/kg every 2 weeks and atezolizumab

Please pass captcha verification before submit form